13 results
Causes of Dyspnea by System #Diagnosis #EM #IM #PCC #Dyspnea #ShortnessOfBreath #Differential #Algorithm #Ddxof
Diagnosis #EM #IM ... #PCC #Dyspnea # ... Differential #Algorithm #Ddxof
Pleural Effusion - Workup, Diagnostic Algorithm #Diagnosis #EM #IM #PCC #Pleural #Effusion #Transudative #Exudative #Differential #Algorithm
Diagnosis #EM #IM ... #PCC #Pleural # ... Lights #Criteria #Ddxof
Algorithm and Causes of an Elevated Hemidiaphragm #Diagnosis #Radiology #EM #IM #PCC #Elevated #Hemidiaphragm #ElevatedHemidiaphragm #Diaphragm
Radiology #EM #IM ... #PCC #Elevated ... Differential #Algorithm #Ddxof
Consensus diagnostic criteria for asthma-COPD overlap syndrome (ACOS) in patients with airflow limitation. COPD=chronic obstructive pulmonary
diagnostic criteria for asthma-COPD ... pulmonary disease; CT ... normal #Diagnosis #PCC ... #IM #ACOS #AsthmaCOPD ... OverlapSyndrome #Asthma
Assessment and Treatment of Severe Asthma, According to Inflammatory Phenotypes, in Patients without a Response to
Treatment of Severe Asthma ... #Management #PCC ... #Asthma #Severe ... Algorithm #Phenotypes #NEJM
An Integrated Multidisciplinary Approach to Assessment and Initial Management of Difficult-to-Treat and Severe Asthma in Adults.
Difficult-to-Treat and Severe Asthma ... glucocorticoids #Management #PCC ... #Asthma #Severe ... DifficultToTreat #Assessment #NEJM
Algorithm for Evaluation of Suspected Pulmonary Embolism #Diagnosis #EM #IM #PCC #PulmonaryEmbolism #Pulmonary #Embolism #DDimer #CTA
Diagnosis #EM #IM ... #PCC #PulmonaryEmbolism ... CTA #Algorithm #Ddxof
Features Associated with Pathobiologic Characteristics of Severe Asthma, According to Phenotype. #Diagnosis #PCC #Asthma #Severe #Phenotypes
Characteristics of Severe Asthma ... #Diagnosis #PCC ... #Asthma #Severe ... Hyperresponsive #Fixed #NEJM
Possible mechanisms for the development of asthma-COPD overlap syndrome (ACOS). Two mechanisms by which ACOS might
development of asthma-COPD ... #Pathophys #PCC ... #IM #ACOS #AsthmaCOPD ... OverlapSyndrome #Asthma
Tezepelumab in Adults with Uncontrolled Asthma - Annualized Rate of Asthma Exacerbations at Week 52, According
with Uncontrolled Asthma ... Annualized Rate of Asthma ... Nitric Oxide #EBM #PCC ... #Asthma #Tezepelumab ... #NEJM